Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20581
-
20582
-
20583
-
20584
-
20585
-
20586
-
20587
-
20588
-
20589
DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20590
DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20591
DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20592
DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20593
DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20594
DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20595
Scopoli’s shearwater and the Yellow-legged mean egg volume synchrony results.
Published 2022“…<p>a) Mean egg volume 95% confidence intervals (grey) of the Scopoli’s shearwater and the Yellow-legged gull (black) breeding at Dragonera Natural Park (2002–2019, Spain). …”
-
20596
Model sensitivity analysis to parameters: <i>k</i><sub>5,<i>P</i></sub>, <i>K</i><sub><i>a</i></sub>, <i>K</i><sub><i>PLC</i></sub>, <i>V</i><sub><i>SERCA</i></sub> and <i>β</i>.
Published 2021“…<b>(D)</b> Decreased <i>V</i><sub><i>SERCA</i></sub> (BV of 0.9 μM s<sup>-1</sup>) increased frequency and duration of the Ca<sup>2+</sup> signal to the point of observing constant activity, whereas increased <i>V</i><sub><i>SERCA</i></sub> decreased frequency to the point of loss of signal in a 60 minute simulation. …”
-
20597
The effectiveness of computerised decision support on antibiotic use in hospitals: A systematic review
Published 2017“…Studies were evaluated for quality using a 10-point rating scale.</p><p>Results</p><p>Eighty-one studies were identified matching the inclusion criteria. …”
-
20598
-
20599
-
20600
Mean fire return interval (mFRI) estimate 1976–2000.
Published 2016“…<p>Mean fire return interval (mFRI) estimate 1976–2000 (A), and its change from the historical period (1951–1975) (B). …”